Ameritas Investment Partners, Inc. - ELIEM THERAPEUTICS INC ownership

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 33 filers reported holding ELIEM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$5,000
-16.7%
5410.0%0.00%
Q4 2021$6,000
-40.0%
5410.0%0.00%
Q3 2021$10,0005410.00%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RA Capital Management 13,150,849$236,452,0003.28%
Monashee Investment Management LLC 305,233$5,488,0001.01%
SAMLYN CAPITAL, LLC 1,681,025$30,225,0000.40%
Woodline Partners LP 387,224$6,962,0000.11%
TUDOR INVESTMENT CORP ET AL 287,294$5,166,0000.08%
CAAS CAPITAL MANAGEMENT LP 75,000$1,349,0000.03%
Hudson Bay Capital Management LP 100,000$1,798,0000.02%
GOLDMAN SACHS GROUP INC 165,952$2,984,0000.00%
HRT FINANCIAL LP 11,797$212,0000.00%
MILLENNIUM MANAGEMENT LLC 71,983$1,294,0000.00%
View complete list of ELIEM THERAPEUTICS INC shareholders